29 Dec | 30 Dec | 31 Dec | 1 Jan | 2 Jan | 3 Jan | 4 Jannews


Dunlop to take up conversion jobs for other tyre majors
Dunlop India Ltd (DIL) is gearing up to play a major role as converter of tyres for other established tyre companies. The conversion job is being taken up to ensure existing installed production facilities at DIL's two factories will do more work.
Back to News Review index page  

Novo Nordisk too cuts prices
Novo Nordisk has reduced the price of human insulin by almost 25 per cent for human insulin vials filled in India, according to Dr Anil Kapur, Managing Director and Vice-President (International Operations), Novo Nordisk India Private Ltd.
Back to News Review index page  

Eli Lilly slashes price of human insulin
ElI Lilly and Company (India) Pvt Ltd has slashed prices of its human insulin brand — Huminsulin. After the price reduction, a 10-ml human insulin vial will cost Rs 145 against the earlier price of Rs 218, the company today said.
Back to News Review index page  

Reliance Infocomm alerts customers
Reliance Infocomm has cautioned subscribers and customers not to make any payments in cash or cheque to anyone except authorised `Point of Sales Agents' and `Dhirubhai Ambani Entrepreneurs'.
Back to News Review index page  

Dr Reddy's ships generic Ibuprofen to America
Dr Reddy's Laboratories Ltd, the Hyderabad-based pharmaceuticals major has announced that it has commenced shipment of prescription Ibuprofen tablets in the dosages of 400mg, 600mg and 800mg to the US market.
Back to News Review index page  

Accounting norms for ESOPs by mid-Feb
The Institute of Chartered Accountants of India (ICAI) hopes to lay down comprehensive accounting norms for Employee Stock Option Schemes (ESOPs) by mid-February.
Back to News Review index page  

Auditors `qualify' Siris accounts
The statutory auditors of Siris Ltd, the Hyderabad-based ailing pharmaceutical company, have qualified the accounts of the company for the year ended March 31, 2002.
Back to News Review index page  

Readers Digest sale stuck over royalty
Royalty payment to the US parent is believed to be the main issue holding up the Tatas' plan to sell the Indian Reader's Digest to the Living Media group. Indian Reader's Digest is published by RDI Print & Publishing Ltd.
Back to News Review index page  

Accountability must be built into corporate governance: Viren Shah
Creating wealth and maintaining a free and just society are essentially two sides of the same coin. Both require broad-based systems of accountability that need to be built into the governance structures of corporations, according to industrialist Viren J. Shah.
Back to News Review index page  

Alind units put up for sale
The process for sale of the various divisions of the ailing Aluminium Industries Ltd (Alind) has been set in motion with tenders being floated inviting bids for take-over of the company's Relays Division and the Switchgear Division.
Back to News Review index page  

SAIL output up 7 per cent in April-Dec
Steel Authority of India Ltd (SAIL) produced 7.34 million tonnes of saleable steel, a growth of 7 per cent during April-December 2002 over the corresponding period last year, according to a company release.
Back to News Review index page  

Nicholas Piramal launches new anti-allergic drug
Nicholas Piramal India Ltd (NPIL) plans to launch 10 new products through its newly-formed respiratory division, ACTIS. The company, which recently acquired Rhone-Poulenc, expects a revenue worth Rs 325-330 crore through ACTIS.
Back to News Review index page  

DD Sen quits Reliance to join Dutch company Petroplus
One of Reliance's key crude oil sourcing people, DD Sen, has quit the company for greener pastures. Sen, who as senior vice-president (supply and trading) was largely responsible for setting up the desk that sources crude worth roughly $5bn every year, is joining Dutch oil company Petroplus. He will head their crude oil sourcing out of Dubai.
Back to News Review index page  

Shreya Life seen in talks to buy Plethico Pharma
Drugmaker Shreya Life Sciences is said to be in talks with Plethico Pharmaceuticals for a deal involving the purchase of a whole or part of Plethico's business. The Rs 135-crore Shreya acquired Tata group firm Rallis India's pharma business in '01 to foray into the Rs 17,000 crore Indian pharmaceutical market.
Back to News Review index page  

State online lottery offers Rs 50-cr jackpot
E-cool Gaming Solutions, an Essel group company, in association with the Maharashtra government, on Friday launched the country's biggest online lottery game with a prize money of Rs 50 crore in an effort to expand its lotteries business.
Back to News Review index page  

Lacoste plans to become 'friendlier'
The famed French apparel brand, Lacoste, is revamping its Indian operations. The company is looking at significant investments to make the brand more accessible to the Indian consumer and cultivate a friendlier image for Lacoste.
Back to News Review index page  

LG to launch low-priced audio systems
LG Electronics India (LGEIL) is planning to market low-end audio products in the country to get a better grip of the market after its high-end products failed to make much headway.
Back to News Review index page  

DRL passes purity test on Grastim
In what could be a second-coming for Dr Reddy's Labs, the final report of the Ganguly Committee, set up to look into the allegations of efficacy and purity of Dr Reddy's DNA biotech drug Grastim, has said that the purity profile of DRL's drug is “almost similar” to Swiss major Roche's Neopogen (Filgrastim), marketed in India exclusively by Nicholas Piramal India.
Back to News Review index page  

Non-tech companies stir up Chennai realty market
Chennai's commercial property scene is looking up. The metro is set to witness slew of major deals soon involving leading corporates like Reliance, Ashok Leyland, Hyundai Motor, ICICI, HSBC and Philips. These are in addition to deals being finalised between the Binny, Kalpathi and Reddy families.
Back to News Review index page  


 search domain-b
  go
 
domain - B : Indian business : News Review : 4 January 2003 : companies